Santana TTN, Monteagudo CA, Del Aguila GA, Galloso PO, Carvajal EJL

Language: Spanish
References: 12
Page: 228-237
PDF size: 238.70 Kb.

ABSTRACT

Background: pre-hypertension is an important risk factor; that is why its stratification and early evaluation is a key element. The sustained-weight test can contribute to such objectives.
Objective: to evaluate the stratification of cardiovascular risk in pre-hypertensive patients attended at the Manuel Ascunce Domenech University Hospital of Camaguey during 2010.
Method: a cross-sectional, descriptive study was conducted. The universe was composed of 167 patients that came to consultation. The sample included 53 patients that fulfilled the inclusion criterion. A form that included the necessary variables to conduct the investigation was designed. The variables were the following: cardiovascular risk factors, stratified cardiovascular risk, and clinical and hypertensive responses to the sustained-weigh test. The form constituted the primary record of the investigation.
Results: there was an association of cardiovascular risk factors and more than the half of the patients presented an intermediate cardiovascular risk. More than the half of the patients presented a hypertensive response after been applied the test. It became more serious the clinical response after test as the cardiovascular risk increased.
Conclusions: the sustained-weight test was useful for the stratification of cardiovascular risk.

REFERENCES

1. León Regal ML. La prueba del peso sostenido: una técnica diagnóstica en el estudio de la hipertensión arterial esencial. Medisur. 2008;6(1)Especial CTS:52-6.

2. Chobanian Aram V, Bakris GL, Black HR, Cushman WG, Green Lee I, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289(21):2560-71.

3. Paragano AJ, Machado R, Abdala A, Cordero DJ, Angel A, Curotto Grasiosi J, et al. Prevalencia de la hipertensión arterial según los distintos componentes del síndrome metabólico y su vínculo con ellos. Rev Argent Cardiol. 2009;77:274-9.

4. Pérez Caballero MD, Dueñas Herrera A, Alfonso Guerra JP, Vázquez Vigoa A, Navarro Despaigne D, Hernández Cueto M, et al. Guía cubana para la prevención, diagnóstico y tratamiento de la hipertensión arterial 2006.Ciudad de La Habana: INFOMED; 2006 [citado 2 Jun 2011]. Disponible en: http://www.hta.sld.cu/node/44

5. Benet Rodríguez M, Espinosa Chang LJ, Apollinaire Peninni JJ, León Regal ML. Hiperreactividad cardiovascular en la predicción de la hipertensión arterial en la comunidad. Medisur. 2006;4(3):33-41.

6. Basterra-Gortari FJ, Bes-Rastrollo M, Seguí-Gómez M, Martínez, Martínez-González MA, Forga L. Tendencias de la obesidad, diabetes mellitus, hipertensión e hipercolesterolemia en España, 1997-2003. Med Clin (Barc). 2007;129(11):405-8.

7. Pérez Caballero MD. La prehipertensión. Rev cubana med. 2008;47(1):1-3.

8. Medrano Alberto MJ, Boix Martínez R, Cerrato Crespán E, Ramírez Santa Pau M. Incidencia y prevalencia de cardiopatía isquémica y enfermedad cerebrovascular en España: revisión sistemática de la literatura. Rev Esp Salud Pública. 2006;80:5-15.

9. Meliá Pérez D, Castañeda Abascal IE, Pulles Cuervo JC. Caracterización de pacientes hipertensos no dispensarizados que acuden a un servicio de urgencias. Rev Cubana Salud Pública. 2009;35(4):1-7.

10. Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged men. Hypertension. 1996;27:1059-64.

11. Chobanian Aram V, Bakris GL, Black HR, Cushman WG, Green Lee I, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289(21):2560-71.

12. Serra N, Miro L. Seguimiento clínico y por diagnóstico no invasivo del paciente arterial. Ana Cir CarD Vas. 2001;7(4):253-270.